N-DIS is a portable, easily deployed, low cost, and sole use disposable infectious disease containment system allowing infectious patients to be safely transported while being fully encapsulated in a medical grade oxygen enriched clear polyethylene membrane. The N-DIS is designed to minimize risk to the patient and front- line personnel. The N-DIS will be critical for first responder and medical staff protection against infectious and contagious pathogens such as SARS-CoV-2 COVID 19, A H5N1 Bird Flu, Human Metapneumovirus HMPV, Monkeypox Clade 1, Ebola and others while infected patients are being transported and/or isolated. Given constant re-exposure to respiratory pathogens, front-line medical personnel and first responders have the second highest rates of serious illness and death.

In 2023, the N-DIS was tested by the U.S. Army’s premier testing facility which reported that the isolation efficacy rating of the N-DIS was greater than 99.99% for viral and bacterial pathogens. The N-DIS can isolate contaminated patients during transport and protect first responders and medical personnel. The N-DIS can also protect vulnerable patients with severely compromised immune systems from airborne and surface pathogens. The N-DIS is easy to use, low cost, disposable, and meets all quarantine protocols. The N-DIS contains the contaminated exhaust from the patient in a HEPA filter. The N-DIS membrane and HEPA filter exhaust system can be disposed of as biohazard waste after the patient is removed from the N-DIS.

The N-DIS supplements standard PPE and captures viral and bacterial particles emitted from a patient’s body, preventing exposure to EMT personnel, first responders, nurses, and physicians from pathogenic biological airborne particulates. The N-DIS will also be useful for U.S. military personnel who are facing an ever-growing challenge from infectious pathogens. Along with rapid isolation of the patient, another critical operational consideration is patient safety. The emplacement of the N-DIS does not cause undue physical discomfort for the patient which would impede rapid and effective isolation. The patient can be transported and monitored comfortably.

The N-DIS is expected to be a market leader based on performance, pricing, portability, and ease of implementation, personnel training, and disposability compared to competing products.